PHARMACOKINETICS OF CHLORAMPHENICOL IN NORMAL AND ESCHERICHIA-COLI INFECTED CHICKENS

被引:8
作者
ATEF, M
ATTA, AH
AMER, AM
机构
[1] Pharmacolozy Department, Faculty of Veterinary Medicine, Cairo University, Giza
关键词
D O I
10.1080/00071669108417384
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
1. Disposition kinetics were compared in healthy chickens and in chickens naturally infected with E. coli following the intravenous, intramuscular and oral administration of chloramphenicol in a single dose of 20 mg/kg body weight. 2. Lower serum chloramphenicol concentrations in diseased chickens were reported after intravenous injection, but they were higher than normal 30 min after intramuscular and oral administration. Following intravenous injection the volume of distribution was increased in diseased chickens. 3. The biological half-life in normal chickens was 8.32 +/- 0.5 h and was prolonged in diseased birds (26.21 +/- 0.2 h). The body clearance of chloramphenicol was reduced in diseased chickens. 4. The rate of absorption of chloramphenicol was delayed after administration via the oral route but the extent of absorption was increased. The maximum concentration was higher and it was reached after a longer time in diseased than in normal chickens after administration by both intramuscular and oral routes.
引用
收藏
页码:589 / 596
页数:8
相关论文
共 20 条
[1]   OUTLINE OF DETAILS FOR MICROBIOLOGICAL ASSAYS OF ANTIBIOTICS - SECOND REVISION [J].
ARRET, B ;
JOHNSON, DP ;
KIRSHBAUM, A .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (11) :1689-+
[2]  
Baggot J. D., 1977, PRINCIPLES DRUG DISP
[3]  
BAGGOT JD, 1980, J AM VET MED ASSOC, V176, P1085
[4]   DISTURBED INTRA-RENAL DISTRIBUTION OF GENTAMICIN IN EXPERIMENTAL PYELONEPHRITIS DUE TO ESCHERICHIA-COLI [J].
BERGERON, MG ;
TROTTIER, S ;
LESSARD, C ;
BEAUCHAMP, D ;
GAGNON, PM .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (03) :436-439
[5]  
BOWMAN WC, 1969, TXB PHARM
[6]  
BRANDER GC, 1982, VET APPLIED PHARM TH
[7]  
BURROWS GE, 1983, AM J VET RES, V44, P1053
[8]  
CLARK CH, 1982, AM J VET RES, V43, P1249
[9]  
HALKIN H, 1981, J PHARMACOL EXP THER, V216, P415
[10]  
JENNER P, 1981, CONCEPTS DRUG METABO, P423